155229-76-8 (氟伐他汀,(3S,5R)-Fluvastatin sodium salt)

(-)-3S,5R-氟伐他汀钠盐;(3S,5R,6E)-7-[3-(4-氟苯基)-1-异丙基-1H-吲哚-2-基]-3,5-二羟基-6-庚烯酸;(3S,5R)-Fluvastatin-D6钠盐;氟伐他汀钠杂质-D6;

6-Heptenoic acid,7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,(3S,5R,6E)-;(-)-3S,5R-FLUVASTATIN SODIUM SALT;(3S,5R) Fluvastatin Sodium Salt;(3S,5R)-Fluvastatin Sodium Salt;6-Heptenoic acid,7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,(3S,5R,...;(3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid;A(non-d);(-)-3S,5R-Fluvastatin-d6 sodiuM salt;(3S,5R)-7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic Acid Sodium Salt;155229-76-8;(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;Fluvastatina (INN-Spanish);C10AA04;(-)-(3S,5R)-fluvastatin;DB-257706;UNII-4L066368AS;[R*,S*-(E)]-(+/-)-7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid, monosodium salt;Fluvastatin (INN);(3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid;FLUVASTATIN [MI];Fluvas (TN);(6E)-erythro7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;(3S,5R)-fluvastatin;BPBio1_000965;6-HEPTENOIC ACID, 7-(3-(4-FLUOROPHENYL)-1-(1-METHYLETHYL)-1H-INDOL-2-YL)-3,5-DIHYDROXY-, (3R,5S,6E)-REL-;(3S,5R)-(-)-fluvastatin;CHEBI:38561;Fluvastatinum [INN-Latin];4L066368AS;Fluvastatine;Fluvastatine [INN-French];rac-(3R,5S,6E)-7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic acid;HSDB 8366;BIDD:GT0839;(6E)-erythro7-(3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid;FLUVASTATIN [VANDF];(3S,5r,6e)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid;Prestwick3_000859;AKOS015896650;BSPBio_000877;fluvastatin;Fluvas;6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (R*,S*-(E))-(+-)-;Fluvastatina [INN-Spanish];DTXSID2020636;BRD-K39716612-236-01-1;FJLGEFLZQAZZCD-JUFISIKESA-N;Fluvastatinum (Latin);CHEBI:5136;6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)- 3,5-dihydroxy-, (3R,5S,6E)-rel-;rac-(3R,5S)-fluvastatin;6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (3R,5S,6E)-;BDBM50248235;Cranoc;FLUVASTATIN [INN];rac-(3R,5S,6E)-7-(3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid;Fluvastatina;FLUVASTATIN [WHO-DD];NSC-758896;(3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoicacid;CHEBI:94603;Fluvastatinum (INN-Latin);SCHEMBL2849;Fluvastatin [INN:BAN];NSC 758896;erythro-(E)-3,5-dihydroxy-7-[3'-(4''-fluorophenyl)-1'-(1''-methylethyl)indol-2'-yl]hept-6-enoic acid;XU 62320;(E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid;D07983;93957-54-1;Fluvastatine (INN-French);XU 62-320;Fluvastatinum;(3S,5R,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;CHEMBL350239;6-Heptenoic acid, 7-(3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-, (R*,S*-(E))-(+-)-;BRD-K03602135-236-02-1;erythro-(E)-3,5-dihydroxy-7-(3'-(4''-fluorophenyl)-1'-(1''-methylethyl)indol-2'-yl)hept-6-enoic acid;DTXCID0065309;rac-(3R,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid;DB01095;(+-)-fluvastatin;C07014;EN300-28265959;SCHEMBL2847;NCGC00164604-10;

FJLGEFLZQAZZCD-JUFISIKESA-N

1S/C24H26FNO4/c1-15(2)26-21-6-4-3-5-20(21)24(16-7-9-17(25)10-8-16)22(26)12-11-18(27)13-19(28)14-23(29)30/h3-12,15,18-19,27-28H,13-14H2,1-2H3,(H,29,30)/b12-11+/t18-,19-/m0/s1

FC1C=CC(=CC=1)C1C2C=CC=CC=2N(C=1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C(C)C